Spine-Tech (SPYN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Spine-Tech (SPYN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stratajema who wrote (102)	1/30/1997 11:00:00 PM
From: Neil_L	of 242

Rodman & Renshaw Inc. initiated coverage of Spine-Tech Inc. (SPYN) with a neutral rating. They said the stock's current valuation may be unwarranted given that the firm sees slower-than-anticipated growth starting in mid- to late 1997. The firm estimated Spine-Tech will lose 28 cents a share in 1996, earn 8 cents in 1997 and earn 42 cents in 1998. Thats probably the reason for todays weakness. IMO, I don't see a whole lot of upside at this point. My guess is that earnings will probably disappoint especially since expectations may be higher given its the first qtr with FDA approval? Not really crazy about options, but IYO what would be the best puts to buy going at least thru that week in Feb. I don't think 15 by then is out of the question given current sentiment. Neil

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next